Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Bing Du Xue Bao = Chinese Journal of Virology|July 14, 2018
[Progress in the Development of Animal Models Supporting Human Adenovirus Infection]Xikui Sun, Xingong Liu, Liqiang FengJournal of Leukocyte Biology|April 22, 2021
ATR kinase activity promotes antibody class switch recombination in B cells through cell cycle regulation without suppressing DSB resection and microhomology usageXikui Sun, Meiling Liu, Jingning Bai, et al.Virologica Sinica|January 4, 2026
Multivalent display of Envelope protein domain III with Mi3 nanoparticles induces protective immunity against lethal Zika virus infection in miceXikui Sun, Huadong Jiang, Wenqiang Yu, et al.Frontiers in Cell and Developmental Biology|December 20, 2021
Multiple DSB Resection Activities Redundantly Promote Alternative End Joining-Mediated Class Switch RecombinationXikui Sun, Jingning Bai, Jiejie Xu, et al.Emerging Microbes & Infections|June 8, 2017
Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern ChinaXuehua Zheng, Xia Rong, Ying Feng, et al.Virologica Sinica|July 3, 2025
Rapid and accurate detection of infectious SARS-CoV-2 by viral receptor capture combined with loop-mediated isothermal amplificationZixiao Yang, Xinrong Zhou, Xikui Sun, et al.Virology|March 19, 2018
Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activityYing Feng, Xikui Sun, Xianmiao Ye, et al.Journal of Virology|June 26, 2020
Human Desmoglein-2 and Human CD46 Mediate Human Adenovirus Type 55 Infection, but Human Desmoglein-2 Plays the Major RolesYing Feng, Changhua Yi, Xinglong Liu, et al.Emerging Microbes & Infections|January 19, 2024
Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrewsXinglong Liu, Zhengfeng Li, Xiao Li, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenovirusesYing Feng, Tao Shu, Liang Li, et al.Pageof 1